Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 8 Sponsors

Jul 8, 2026 · Assembly

Approved P.L.2026, c.40.

Jun 30, 2026 · Assembly

Passed by the Assembly (76-2-1)

Jun 30, 2026 · Senate

Received in the Senate without Reference, 2nd Reading

Jun 30, 2026 · Assembly

Substituted for S4194/4210 (SCS)

Jun 30, 2026 · Senate

Passed Senate (Passed Both Houses) (38-2)

Jun 23, 2026 · Assembly

Transferred to Assembly State and Local Government Committee

Jun 23, 2026 · Assembly

Reported from Assembly Comm. as a Substitute, 2nd Reading

May 4, 2026 · Assembly

Introduced, Referred to Assembly Health Committee

PASSAGE PROBABILITY

32.8% Uncertain

Why this number

Stage base Passed First Chamber — base rate 40%, measured from NJ's completed sessions
Momentum +4 70/100 from the pace of recorded action
Time since last action -12 94 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.